Consensus guidelines for the validation of qRT-PCR assays in clinical research by the CardioRNA consortium.

PCR RNA assay validation clinical research assays noncoding RNA

Journal

Molecular therapy. Methods & clinical development
ISSN: 2329-0501
Titre abrégé: Mol Ther Methods Clin Dev
Pays: United States
ID NLM: 101624857

Informations de publication

Date de publication:
10 Mar 2022
Historique:
entrez: 4 2 2022
pubmed: 5 2 2022
medline: 5 2 2022
Statut: epublish

Résumé

Despite promising findings, quantitative PCR (qPCR)-based tests for RNA quantification have experienced serious limitations in their clinical application. The noticeable lack of technical standardization remains a huge obstacle in the translation of qPCR-based tests. The incorporation of qPCR-based tests into the clinic will benefit from guidelines for clinical research assay validation. This will ultimately impact the clinical management of the patient, including diagnosis, prognosis, prediction, monitoring of the therapeutic response, and evaluation of toxicity. However, clear assay validation protocols for biomarker investigation in clinical trials using molecular assays are currently lacking

Identifiants

pubmed: 35118162
doi: 10.1016/j.omtm.2021.12.007
pii: S2329-0501(22)00001-8
pmc: PMC8792405
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

171-180

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

D.d.G.-C. holds a patent on miRNAs as biomarkers. Y.D. holds patents related to diagnostic and therapeutic applications of RNAs. The other authors declare no competing interests.

Références

Biopreserv Biobank. 2018 Dec;16(6):467-476
pubmed: 30234371
Nucleic Acids Res. 2005 Jan 13;33(1):e9
pubmed: 15653630
Electrophoresis. 2015 Sep;36(17):2072-81
pubmed: 25998866
Nucleic Acids Res. 2012 Aug;40(15):e115
pubmed: 22730293
Biopreserv Biobank. 2012 Dec;10(6):532-42
pubmed: 24845140
Alzheimers Res Ther. 2020 Dec 5;12(1):163
pubmed: 33278902
PLoS One. 2013;8(3):e57841
pubmed: 23472110
Cancer Res. 2004 Aug 1;64(15):5245-50
pubmed: 15289330
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Genome Biol. 2007;8(2):R19
pubmed: 17291332
J Cancer. 2018 Jun 5;9(13):2249-2265
pubmed: 30026820
Br J Pharmacol. 2008 Feb;153(4):646-56
pubmed: 17876307
Cell Rep. 2019 Dec 17;29(12):4212-4222.e5
pubmed: 31851944
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
pubmed: 12824337
BMC Bioinformatics. 2017 Sep 6;18(1):400
pubmed: 28877663
Sci Rep. 2019 Feb 7;9(1):1584
pubmed: 30733582
Biomol Detect Quantif. 2017 Dec 18;15:1-5
pubmed: 29276692
J Cell Physiol. 2019 May;234(5):5451-5465
pubmed: 30471116
Pharm Res. 2006 Feb;23(2):312-28
pubmed: 16397743
EJIFCC. 2009 Jan 20;19(4):203-11
pubmed: 27683318

Auteurs

David de Gonzalo-Calvo (D)

Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, 25198 Lleida, Spain.
CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, 28029 Madrid, Spain.

Monica Marchese (M)

Integrated Bed to Bench Operations (IBBO), Luxembourg Institute of Health, 1445 Strassen, Luxembourg.

Jan Hellemans (J)

Biogazelle, 9052 Zwijnaarde, Belgium.

Fay Betsou (F)

Laboratoire National de Santé (LNS), 3555 Dudelange, Luxembourg.

Nanna Lond Skov Frisk (NL)

Department of Science and Environment, Roskilde University, 4000 Roskilde, Denmark.
Department of Clinical Immunology, Naestved Hospital, 4700 Naestved, Denmark.

Louise Torp Dalgaard (LT)

Department of Science and Environment, Roskilde University, 4000 Roskilde, Denmark.

Päivi Lakkisto (P)

Minerva Foundation Institute for Medical Research, 00290 Helsinki, Finland.
Department of Clinical Chemistry, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.

Carole Foy (C)

National Measurement Laboratory, LGC, Teddington TW11 0LY, UK.

Andreas Scherer (A)

Institute for Molecular Medicine Finland FIMM, Helsinki Institute for Life Science HiLIFE, University of Helsinki, 00014 Helsinki, Finland.
European Research Infrastructure for Translational Medicine EATRIS, 1081 HZ Amsterdam, the Netherlands.

María Laura Garcia Bermejo (ML)

European Research Infrastructure for Translational Medicine EATRIS, 1081 HZ Amsterdam, the Netherlands.
Biomarkers and Therapeutic Targets Group, Ramon y Cajal Health Research Institute (IRYCIS), RedinRen, 28034 Madrid, Spain.

Yvan Devaux (Y)

Cardiovascular Research Unit, Department of Population Health, Luxembourg Institute of Health, 1A-B rue Edison, 1445 Strassen, Luxembourg.

Classifications MeSH